Covered recipient · General Payments record
NATALIE MONTECALVO MAIORCA
Eye and Vision Services Providers Optometrist
General Payments · PY2020–2024
$1,929.42
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $870.51 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $424.02 | 10 |
| Tarsus Pharmaceuticals, Inc. | $262.73 | 3 |
| CooperVision Inc. | $141.81 | 2 |
| Dompe US, Inc. | $26.06 | 1 |
| Bausch & Lomb Americas Inc. | $15.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $16.41 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670203 | CMS |
| Alcon Vision LLC | $9.88 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670193 | CMS |
| Alcon Vision LLC | $12.05 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670195 | CMS |
| Alcon Vision LLC | $13.42 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670197 | CMS |
| Alcon Vision LLC | $16.14 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670201 | CMS |
| Alcon Vision LLC | $124.91 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670209 | CMS |
| Alcon Vision LLC | $7.74 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670191 | CMS |
| Alcon Vision LLC | $104.85 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670205 | CMS |
| Alcon Vision LLC | $104.85 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670207 | CMS |
| Alcon Vision LLC | $13.77 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110670199 | CMS |
| Bausch & Lomb Americas Inc. | $15.89 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140417685 | CMS |
| CooperVision Inc. | $124.80 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145526525 | CMS |
| CooperVision Inc. | $17.01 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145526565 | CMS |
| Dompe US, Inc. | $26.06 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151412264 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.31 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139114331 | CMS |
| Tarsus Pharmaceuticals, Inc. | $114.08 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139114333 | CMS |
| Tarsus Pharmaceuticals, Inc. | $125.34 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139114335 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.